Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.
T Forst,E Karagiannis,G Lübben,C Hohberg,T Schöndorf,G Dikta,M Drexler,M Morcos,W Dänschel,M Borchert,A Pfützner
Atherosclerosis 2008 3;197(1):311-7

Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
HR Black,B Davis,J Barzilay,C Nwachuku,C Baimbridge,H Marginean,JT Wright,J Basile,ND Wong,P Whelton,RA Dart,U Thadani
Diabetes Care 2008 2;31(2):353-60

Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation.
Diabetes Care 2007 9;30(9):2399-400

Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels.
JA Sugden,JI Davies,MD Witham,AD Morris,AD Struthers
Diabet Med 2008 3;25(3):320-5

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.
R Christensen,PK Kristensen,EM Bartels,H Bliddal,A Astrup
Lancet 2007 11;370(9600):1706-13

Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results.
LM Ruilope,JP Després,A Scheen,X Pi-Sunyer,G Mancia,A Zanchetti,L Van Gaal
J Hypertens 2008 2;26(2):357-367

Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study.
PL Lutsey,LM Steffen,J Stevens
Circulation 2008 2;117(6):754-61

Vitamin D deficiency and risk of cardiovascular disease.
TJ Wang,MJ Pencina,SL Booth,PF Jacques,E Ingelsson,K Lanier,EJ Benjamin,RB D'Agostino,M Wolf,RS Vasan
Circulation 2008 1;117(4):503-11

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial.
M Miller,CP Cannon,SA Murphy,J Qin,KK Ray,E Braunwald
J Am Coll Cardiol 2008 2;51(7):724-730

Effect of a multifactorial intervention on mortality in type 2 diabetes.
P Goede,H Lund-Andersen,HH Parving,O Pedersen
N Engl J Med 2008 2;358(6):580-91

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
FJ Zieve,MF Kalin,SL Schwartz,MR Jones,WL Bailey
Clin Ther 2007 1;29(1):74-83

Effects of Maximal Doses of Atorvastatin Versus Rosuvastatin on Small Dense Low-Density Lipoprotein Cholesterol Levels.
M Ai,S Otokozawa,BF Asztalos,K Nakajima,E Stein,PH Jones,EJ Schaefer
Am J Cardiol 2008 2;101(3):315-318

Relation of cumulative weight burden to vascular endothelial dysfunction in obesity.
JM Arkin,R Alsdorf,S Bigornia,J Palmisano,R Beal,N Istfan,D Hess,CM Apovian,N Gokce
Am J Cardiol 2008 1;101(1):98-101

Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
EM deGoma,NJ Leeper,PA Heidenreich
J Am Coll Cardiol 2008 1;51(1):49-55

Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis.
C Willi,P Bodenmann,WA Ghali,PD Faris,J Cornuz
JAMA 2007 12;298(22):2654-64

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
PM Kearney,L Blackwell,R Collins,A Keech,J Simes,R Peto,J Armitage,C Baigent
Lancet 2008 1;371(9607):117-25

Insulin gene mutations as a cause of permanent neonatal diabetes.
J Støy,EL Edghill,SE Flanagan,H Ye,VP Paz,A Pluzhnikov,JE Below,MG Hayes,NJ Cox,GM Lipkind,RB Lipton,SA Greeley,AM Patch,S Ellard,DF Steiner,AT Hattersley,LH Philipson,GI Bell
Proc Natl Acad Sci U S A 2007 9;104(38):15040-4

Is glycemic control improving in U.S. adults?
TJ Hoerger,JE Segel,EW Gregg,JB Saaddine
Diabetes Care 2008 1;31(1):81-6

Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.
G Bolli,F Dotta,E Rochotte,SE Cohen
Diabetes Obes Metab 2008 1;10(1):82-90